Santen Pharmaceutical Co., Ltd. American Depositary Receipt (SNPHY)
OTC
Real-time Data
01:30 PM
Day's Range
12.8852 wk Range
9.22Overview - SNPHY - Santen Pharmaceutical Co., Ltd. American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
-474.53M
P/E (Trailing)
‪16.45‬
P/E (Forward)
‪16.23‬
PEG Ratio
‪2.05‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪2.02‬
EV / EBITDA
‪-1.15‬
Profitability
Profit Margin
‪13.25%‬
Operating Margin
‪11.77%‬
Return on Assets
‪7.09%‬
Return on Equity
‪13.42%‬
Ownership
Shares Outstanding
321.68M
Float
314.54M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
50-Day Avg
‪12.49‬
200-Day Avg
‪11.28‬
Dividends
Payout Ratio
‪32.34%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SNPHY - Santen Pharmaceutical Co., Ltd. American Depositary Receipt
Peers - SNPHY - Santen Pharmaceutical Co., Ltd. American Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
- SNPHYOTCSanten Pharmaceutical Co., Ltd. American Depositary Receipt4.27BMarket Cap+13.76%52-week change19.21P/E (Trailing)‪12.81%‬Profit Margin
- RHHBFOTCRoche Holding AG372.96BMarket Cap+29.50%52-week change24.39P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSEFOTCNovartis AG310.95BMarket Cap+25.48%52-week change23.81P/E (Trailing)‪22.50%‬Profit Margin
- NONOFOTCNovo Nordisk A/S207.17BMarket Cap-18.75%52-week change11.42P/E (Trailing)‪35.34%‬Profit Margin
- GLAXFOTCGSK plc101.34BMarket Cap+23.39%52-week change15.94P/E (Trailing)‪14.52%‬Profit Margin
- CHGCYOTCChugai Pharmaceutical Co. Ltd.71.81BMarket Cap+2.52%52-week change24.38P/E (Trailing)‪35.10%‬Profit Margin
- BAYZFOTCBayer AG55.43BMarket Cap+41.82%52-week change28.11P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - SNPHY - Santen Pharmaceutical Co., Ltd. American Depositary Receipt
About
Santen Pharmaceutical Co., Ltd. American Depositary Receipt is a type of equity security that represents shares of Santen Pharmaceutical, a leading Japanese company focused on ophthalmology and related healthcare fields. This ADR allows investors in the United States to gain exposure to Santen Pharmaceutical's stock,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
